Mono Pharmacare IPO listing price is ₹ 30.45, issue price is ₹ 28.00, and currently trading at ₹ 24.50 as on May 20, 2025. Mono Pharmacare IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Mono Pharmacare IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Unistone Capital is the merchant banker of Mono Pharmacare IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 11th April 2023.
Mono Pharmacare IPO offer price is ₹ 28.00 and got listed at ₹ 30.45. Read Mono Pharmacare IPO details mentioned above.The IPO of Mono Pharmacare Limited was listed on 7th September 2023. As of today, Mono Pharmacare IPO is trading at ₹ 24.50, compared to the previous day’s close of ₹ 25.00. Read the report above for detailed IPO performance.
The issue price of Mono Pharmacare IPO was ₹ 28.00 per equity share.
Mono Pharmacare IPO was listed at ₹30.45 on the stock exchange on 7th September 2023. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 20, 2025, the current market price of Mono Pharmacare IPO is ₹ 24.50.
The 52-week high for Mono Pharmacare IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Mono Pharmacare IPO listed at ₹ 30.45 against the issue price of ₹ 28.00 per equity share, showing a listing day gain/loss of 2.45 (8.75%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Mono Pharmacare IPO stock moved from its listing price of ₹ 30.45 to the current price of ₹24.50 per equity share, reflecting a change of -19.54% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Mono Pharmacare IPO issue date of May 20, 2025 and CMP of ₹24.50, the estimated CAGR is approximately -7.54%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Mono Pharmacare IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Mono Pharmacare Financial Review Page
Merchant Banker(s) of Mono Pharmacare IPO: Unistone Capital Private Limited
Mono Pharmacare IPO subscription was 13.42 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Mono Pharmacare IPO listed at a listing price of 30.45 against the offer price of 28.00.
The current market price of Mono Pharmacare is 24.50.
Why Us?